Portola Pharmaceuticals, Inc.
PTLA
PTLA was delisted on the 1st of July, 2020.
160 hedge funds and large institutions have $1.82B invested in Portola Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 64 increasing their positions, 33 reducing their positions, and 13 closing their positions.
215% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 13
94% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 33
92% more call options, than puts
Call options by funds: $1.62M | Put options by funds: $848K
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
44% more capital invested
Capital invested by funds: $1.26B → $1.82B (+$556M)
20% more funds holding
Funds holding: 133 → 160 (+27)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$23.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.5M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
+$13.7M |
| 4 |
Millennium Management
New York
|
+$11.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
Abingworth
London,
United Kingdom
|
-$20M |
| 2 |
OTPPB
Ontario Teachers' Pension Plan Board
Toronto,
Ontario, Canada
|
-$10.4M |
| 3 |
FAM
Fred Alger Management
New York
|
-$8.44M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$6.47M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$5.57M |
PTLA Hedge Fund Activity: Q1 2015 in Review
160 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Portola Pharmaceuticals, Inc. (PTLA) for Q1 2015, worth a combined $1.82B — up 44% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new PTLA positions and 13 closed out — a net gain of 28 holders — while 64 added to existing stakes and 33 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $23.2M. The largest seller was Abingworth, cutting an estimated $20M.
- 160 institutional investors held Portola Pharmaceuticals, Inc. (PTLA) as of Q1 2015, up from 133 in Q4 2014.
- Funds reported $1.82B of Portola Pharmaceuticals, Inc. stock for Q1 2015, up 44% quarter-over-quarter.
- 41 funds opened new Portola Pharmaceuticals, Inc. positions in Q1 2015 and 13 closed out, a net change of +28 holders.
- The largest Portola Pharmaceuticals, Inc. buyer in Q1 2015 was Wellington Management Group, an estimated $23.2M added.
- The largest Portola Pharmaceuticals, Inc. seller in Q1 2015 was Abingworth, an estimated $20M sold.
Based on aggregated 13F filings for Q1 2015.